Regenxbio Inc
NASDAQ:RGNX
Regenxbio Inc
NASDAQ:RGNX
Price:
16.01 USD
-1.36%
Market Closed
Updated:
May 17, 2024
Net Margin
Regenxbio Inc
Regenxbio Inc
-300%
Current
-150%
Average
-8.2%
Industry
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=-300%
Net Income
/
-260.2m
Revenue
86.7m
Net Margin Across Competitors
| Country | US |
| Market Cap | 785.2m USD |
| Net Margin |
-300%
|
| Country | US |
| Market Cap | 290.2B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 168.8B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 113.6B USD |
| Net Margin |
37%
|
| Country | US |
| Market Cap | 106.7B USD |
| Net Margin |
29%
|
| Country | AU |
| Market Cap | 138.6B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 84.6B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 50.8B USD |
| Net Margin |
-116%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 33.5B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 39.4T KRW |
| Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Regenxbio Inc.
See Also
Discover More
What is Net Margin?
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=-300%
Net Income
/
-260.2m
Revenue
86.7m
What is the Net Margin of Regenxbio Inc?
Based on Regenxbio Inc's most recent financial statements, the company has Net Margin of -300%.
You don't have any saved screeners yet
